On March 1, 2024, Aimed Alliance submitted a Citizen Petition to the Food and Drug Administration (FDA) regarding international importation by alternative funding programs. The Petition asks the FDA to clarify (1) whether third-party companies that partner with employer-sponsored health plans can legally require employees to import their prescription drugs from outside the United States; (2) whether third-party companies that partner with employer-sponsored health plans can import prescription drugs on behalf of consumers enrolled in an alternative funding program; and to (3) provide an explanation of existing reporting pathways for individuals and organizations to notify the FDA of instances where entities engage in such unauthorized practices. The FDA must respond within 180 days of submission. Read the Citizen Petition here.
Last Updated on April 1, 2024 by Aimed Alliance
